Critical role of the STAT3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation – the rat isolated working heart
Authors:
Open Access
- 13 October 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (3) , 633-647
Abstract
BACKGROUND AND PURPOSE: Ischemia‐reperfusion injury plays an important role in the development of primary allograft failure after heart transplantation. Inhibition of the Na+/H+ exchanger is one of the most promising therapeutic strategies for treating ischemia‐reperfusion injury. Here we have characterized the cardioprotective efficacy of zoniporide and the underlying mechanisms in a model of myocardial preservation using rat isolated working hearts.EXPERIMENTAL APPROACH: Rat isolated hearts subjected to 6 h hypothermic (1–4°C) storage followed by 45 min reperfusion at 37°C were treated with zoniporide at different concentrations and timing. Recovery of cardiac function, levels of total and phosphorylated protein kinase B, extracellular signal‐regulated kinase 1/2, glycogen synthase kinase‐3β and STAT3 as well as cleaved caspase 3 were measured at the end of reperfusion. Lactate dehydrogenase release into coronary effluent before and post‐storage was also measured.KEY RESULTS: Zoniporide concentration‐dependently improved recovery of cardiac function after reperfusion. The functional recovery induced by zoniporide was accompanied by up‐regulation of p‐extracellular signal‐regulated kinase 1/2 and p‐STAT3, and by reduction in lactate dehydrogenase release and cleaved caspase 3. There were no significant differences in any of the above indices when zoniporide was administered before, during or after ischemia. The STAT3 inhibitor, stattic, abolished zoniporide‐induced improvements in functional recovery and up‐regulation of p‐STAT3 after reperfusion.CONCLUSIONS AND IMPLICATIONS: Zoniporide is a potent cardioprotective agent and activation of STAT3 plays a critical role in the cardioprotective action of zoniporide. This agent shows promise as a supplement to storage solutions to improve preservation of donor hearts.Keywords
This publication has 62 references indexed in Scilit:
- MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblastsCardiovascular Research, 2010
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Dexamethasone-induced cardioprotection: A role for the phosphatase MKP-1?Life Sciences, 2009
- Regulating RISK: a role for JAK-STAT signaling in postconditioning?American Journal of Physiology-Heart and Circulatory Physiology, 2008
- Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusionBasic Research in Cardiology, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- Sodium/hydrogen exchange inhibition with cariporide reduces leukocyte adhesion via P‐selectin suppression during inflammationBritish Journal of Pharmacology, 2008
- NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transitionCardiovascular Research, 2007
- Novel functional interaction between Na+/H+exchanger 1 and tyrosine phosphatase SHP-2American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature Cell Biology, 2003